Stem cells are a group of multipotent cells with the self-renewal ability. In certain conditions, they can differentiate into many functional cells, which have the potential to regenerate tissues and organs and even the human body. Stem cell technologies, or regenerative medicine technologies, are the most prosperous and fast developing in the biotechnology field.

Stem cell and regenerative medicine industry is one of the most prosperous and fast developing industries in China and in the world. Promoting the development of this industry has important and realistic effects on human health.

The translational research platform co-established by Guanhao Biotech and Peking University will get together word leading technologies, first class experts, and industrial capitals. The platform includes a hospital-a clinical medicine center with lab facilities; an autologous cell clinical application demonstration platform, the according GMP standards and the clinical verification system.

We have the intellectual support from  mang universities. We established a patent pool of stem cell and regenerative medicine industry; introduced world-wide stem cell translational technologies and carried on unified management and operation;  Based on the advantages of the platform, we would collaborate with global partners, face the market, apply cutting-edge technologies on tricky diseases and bring benefits on patents’ health.


SitemapQR code

Copyright 冠昊生物科技股份有限公司. 粵ICP備12069953號

网上的棋牌是不是假的 甘肃快3彩票技巧 在线配资公司专业久联优配 河南泳坛夺金看号技巧 腾讯5分彩开奖 青海快3最新结果 股票大盘是指什么意 手机麻将赢真钱微信群 炒股怎么开户流程 安徽十一选五一定牛专家推荐 股票配资平台是合法的么